Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 2/3 1

Status

Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5NETWORK 4NIH 2FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 4Stage I Prostate Adenocarcinoma AJCC v7 1Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × nilutamide × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

NCT01786265 2026-02-20

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
310 enrolled
Genitourinary

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Completed
306 enrolled
Genitourinary

Prostatic Neoplasms

NCT00918385 2014-10-29

ARS

Duke University

Phase 2 Terminated
57 enrolled 8 charts
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT00175396 2014-03-17

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

University of British Columbia

Phase 3 Unknown
400 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡